Term ended Oct 22, 2024 · Medium confidence
20-year base term ended Oct 22, 2024
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,927,863), so the cap could be lower.
Oct 22, 2004
Oct 22, 2024
Apr 16, 2019
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 22, 2004, when application PCT/US2004/035302, the earliest non-provisional in its chain, was filed (this one was filed Sep 14, 2015) | Oct 22, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,927,863, US 8,268,582, US 9,873,746) | resolves to Oct 22, 2024, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Oct 22, 2024 | Medium confidence |
This family
| Application PCT/US2004/035302 | PCT application no patent term | no patent term |
| US 7,927,863 | In force no later than Nov 2027 | no later than Nov 2027 |
| US 8,268,582 | Term ended Jun 2026 | Jun 2026 |
| US 9,873,746 | Term ended May 2025 | May 2025 |
| US 8,709,756 | Term ended Oct 2024 | Oct 2024 |
| US 10,155,819 | Term ended Oct 2024 | Oct 2024 |
| US 10,259,883 | this patent Oct 2024 | Oct 2024 |
| US 11,447,560 | Term ended May 2025 | May 2025 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 23, 2020 Reel 53020, frame 331 | Alderbio Holdings LLC | H. Lundbeck A/S | Assignment of Assignor's Interest |
| Sep 3, 2020 Reel 53681, frame 224 | Alder Biopharmaceuticals, Inc. | Lundbeck Seattle Biopharmaceuticals, Inc. | Change of Name |
| Sep 3, 2020 Reel 54161, frame 877 | Lundbeck Seattle Biopharmaceuticals, Inc. | H. Lundbeck A/S. | Assignment of Assignor's Interest |
| Jun 2, 2021 Reel 56449, frame 543 | Lundbeck Seattle Biopharmaceuticals, Inc. | H. Lundbeck A/S | Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 054161 Frame: 0877. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 7,927,863, US 8,268,582, US 9,873,746, ends no earlier than this term, so it caps nothing.